Trazuma Injection 440 mg/20 ml contains Trastuzumab, a monoclonal antibody used in targeted cancer therapy. It is specifically designed to act against cancers that overexpress the HER2 (human epidermal growth factor receptor 2) protein. By targeting HER2 receptors, Trastuzumab helps slow or stop the growth of cancer cells while minimizing damage to normal cells.

It is widely used in oncology for the treatment of HER2-positive breast cancer and certain gastric cancers. Trazuma Injection is administered in hospitals under strict medical supervision as part of a comprehensive cancer treatment plan.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each vial contains:

• Trastuzumab 440 mg in 20 ml solution

Available as a sterile concentrate for intravenous infusion.

Indications

Trazuma Injection is indicated for:

• HER2-positive breast cancer (early and metastatic)
• HER2-positive gastric or gastroesophageal junction cancer
• Adjuvant therapy after surgery and chemotherapy in selected cases
• Combination therapy with other anticancer agents as prescribed by an oncologist

Mechanism of Action

Trastuzumab binds selectively to the HER2 receptor present on cancer cells. This blocks the receptor’s signaling pathways that promote cell growth and division. It also helps the immune system recognize and destroy HER2-positive cancer cells.

Through these actions, Trastuzumab slows tumor progression and improves treatment outcomes in eligible patients.

Dosage and Administration

Trazuma Injection must be administered only under the supervision of a qualified oncologist.

General administration guidelines include:

• Given as an intravenous infusion
• Initial loading dose followed by maintenance doses
• Dose depends on body weight, cancer type, and treatment protocol
• Administered in cycles, often in combination with chemotherapy

Close monitoring is required during infusion, especially during the first dose.

Benefits of Trazuma Injection

• Targeted therapy for HER2-positive cancers
• Slows tumor growth and spread
• Improves survival rates in breast cancer patients
• Can be used in combination with chemotherapy
• Reduces risk of cancer recurrence in early-stage disease

Possible Side Effects

Common and serious side effects may include:

• Fever and chills during infusion
• Fatigue
• Nausea
• Headache
• Diarrhea
• Heart-related effects (reduced heart function, cardiomyopathy)
• Infusion-related reactions (rare but serious)

Patients receiving Trastuzumab require regular cardiac monitoring.

Precautions and Warnings

• Cardiac function must be assessed before and during treatment.
• Not suitable for patients with severe heart disease without specialist advice.
• Risk of infusion reactions is highest during initial administration.
• Pregnancy must be avoided during treatment and for some time after therapy.
• Use only under strict oncologist supervision.
• Regular monitoring is essential for safety and effectiveness.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children
• Do not shake the vial

Conclusion

Trazuma Injection 440 mg/20 ml (Trastuzumab) is a targeted anticancer therapy used for HER2-positive breast and gastric cancers. By specifically blocking HER2 receptors, it helps slow cancer progression and improve patient outcomes. Due to its potent effects and potential cardiac risks, it must be used only under specialist supervision with regular monitoring.